Press / Medias
LNC secure 6,5 million euros funding for microbiota-focused strategy – looking to IPO
Oct 2, 2017
LNC Therapeutics has raised €6.5m in a Series C funding round as the company announces a new chief science officer and steps up an ‘ambitious’ microbiota-orientated strategy that it hopes will drive an IPO by the end of 2019.
In the same category
Press / Medias
EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic...
Sep 13, 2021
more +
Press / Medias
Press / Medias